thalidomide has been researched along with s-nitroso-n-acetylpenicillamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Chatterjee, S; Indhumathy, M; Kolluru, GK; Rajaram, M; Saranya, R; Tamilarasan, KP | 1 |
2 other study(ies) available for thalidomide and s-nitroso-n-acetylpenicillamine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Thalidomide attenuates nitric oxide mediated angiogenesis by blocking migration of endothelial cells.
Topics: Actins; Angiogenesis Inhibitors; Animals; Biopolymers; Cells, Cultured; Chick Embryo; Cytoskeleton; Endothelial Cells; Endothelium, Vascular; Humans; Neovascularization, Physiologic; Nitric Oxide; Nitric Oxide Donors; S-Nitroso-N-Acetylpenicillamine; Thalidomide; Umbilical Veins; Wound Healing; Yolk Sac | 2006 |